Previous Article | Next Article 
Journal of Virology, October 2001, p. 8899-8908, Vol. 75, No. 19
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.19.8899-8908.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Hyperattenuated Recombinant Influenza A Virus
Nonstructural-Protein-Encoding Vectors Induce Human Immunodeficiency
Virus Type 1 Nef-Specific Systemic and Mucosal Immune
Responses in Mice
Boris
Ferko,*
Jana
Stasakova,
Sabine
Sereinig,
Julia
Romanova,
Dietmar
Katinger,
Brigitte
Niebler,
Hermann
Katinger, and
Andrej
Egorov
Institut für Angewandte Mikrobiologie,
Universität für Bodenkultur, A-1190 Vienna,
Austria
Received 20 March 2001/Accepted 22 June 2001
We have generated recombinant influenza A viruses belonging to the
H1N1 and H3N2 virus subtypes containing an insertion of the 137 C-terminal amino acid residues of the human immunodeficiency virus type
1 (HIV-1) Nef protein into the influenza A virus nonstructural-protein (NS1) reading frame. These viral vectors were found to be genetically stable and capable of growing efficiently in embryonated chicken eggs
and tissue culture cells but did not replicate in the murine respiratory tract. Despite the hyperattenuated phenotype of
influenza/NS-Nef viruses, a Nef and influenza virus
(nucleoprotein)-specific CD8+-T-cell response was detected
in spleens and the lymph nodes draining the respiratory tract after a
single intranasal immunization of mice. Compared to the primary
response, a marked enhancement of the CD8+-T-cell response
was detected in the systemic and mucosal compartments, including mouse
urogenital tracts, if mice were primed with the H1N1 subtype vector and
subsequently boosted with the H3N2 subtype vector. In addition,
Nef-specific serum IgG was detected in mice which were immunized twice
with the recombinant H1N1 and then boosted with the recombinant H3N2
subtype virus. These findings may contribute to the development of
alternative immunization strategies utilizing hyperattenuated live
recombinant influenza virus vectors to prevent or control infectious
diseases, e.g., HIV-1 infection.
*
Corresponding author. Mailing address: Institute of
Applied Microbiology, Muthgasse 18B, A-1190 Vienna, Austria. Phone:
43/1 36006-6593 Fax: 43/1 36006-1249. E-mail:
b.ferko{at}iam.boku.ac.at.
Journal of Virology, October 2001, p. 8899-8908, Vol. 75, No. 19
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.19.8899-8908.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Ferko, B., Kittel, C., Romanova, J., Sereinig, S., Katinger, H., Egorov, A.
(2006). Live Attenuated Influenza Virus Expressing Human Interleukin-2 Reveals Increased Immunogenic Potential in Young and Aged Hosts. J. Virol.
80: 11621-11627
[Abstract]
[Full Text]
-
Sereinig, S., Stukova, M., Zabolotnyh, N., Ferko, B., Kittel, C., Romanova, J., Vinogradova, T., Katinger, H., Kiselev, O., Egorov, A.
(2006). Influenza Virus NS Vectors Expressing the Mycobacterium tuberculosis ESAT-6 Protein Induce CD4+ Th1 Immune Response and Protect Animals against Tuberculosis Challenge.. CVI
13: 898-904
[Abstract]
[Full Text]
-
Gherardi, M. M., Esteban, M.
(2005). Recombinant poxviruses as mucosal vaccine vectors. J. Gen. Virol.
86: 2925-2936
[Abstract]
[Full Text]
-
Falcon, A. M., Fernandez-Sesma, A., Nakaya, Y., Moran, T. M., Ortin, J., Garcia-Sastre, A.
(2005). Attenuation and immunogenicity in mice of temperature-sensitive influenza viruses expressing truncated NS1 proteins. J. Gen. Virol.
86: 2817-2821
[Abstract]
[Full Text]
-
Kittel, C., Ferko, B., Kurz, M., Voglauer, R., Sereinig, S., Romanova, J., Stiegler, G., Katinger, H., Egorov, A.
(2005). Generation of an Influenza A Virus Vector Expressing Biologically Active Human Interleukin-2 from the NS Gene Segment. J. Virol.
79: 10672-10677
[Abstract]
[Full Text]
-
Ferko, B., Stasakova, J., Romanova, J., Kittel, C., Sereinig, S., Katinger, H., Egorov, A.
(2004). Immunogenicity and Protection Efficacy of Replication-Deficient Influenza A Viruses with Altered NS1 Genes. J. Virol.
78: 13037-13045
[Abstract]
[Full Text]
-
Garulli, B., Kawaoka, Y., Castrucci, M. R.
(2004). Mucosal and Systemic Immune Responses to a Human Immunodeficiency Virus Type 1 Epitope Induced upon Vaginal Infection with a Recombinant Influenza A Virus. J. Virol.
78: 1020-1025
[Abstract]
[Full Text]
-
Efferson, C. L., Schickli, J., Ko, B. K., Kawano, K., Mouzi, S., Palese, P., Garcia-Sastre, A., Ioannides, C. G.
(2003). Activation of Tumor Antigen-Specific Cytotoxic T Lymphocytes (CTLs) by Human Dendritic Cells Infected with an Attenuated Influenza A Virus Expressing a CTL Epitope Derived from the HER-2/neu Proto-Oncogene. J. Virol.
77: 7411-7424
[Abstract]
[Full Text]
-
Gherardi, M. M., Najera, J. L., Perez-Jimenez, E., Guerra, S., Garcia-Sastre, A., Esteban, M.
(2003). Prime-Boost Immunization Schedules Based on Influenza Virus and Vaccinia Virus Vectors Potentiate Cellular Immune Responses against Human Immunodeficiency Virus Env Protein Systemically and in the Genitorectal Draining Lymph Nodes. J. Virol.
77: 7048-7057
[Abstract]
[Full Text]